Abstract 1757: Synergy of BCL-2 and MEK/HDAC inhibition in IBC and non-IBC models: Potential for a first IBC specific therapy
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Hassan Zbib, Habib Serhan, Maryam Nakhjiri, Rhea Raghavan, Tusharika Rastogi, Peter J. Ulintz, Aki Morikawa, Nathan Merrill, Sofia Merajver
Institution: University of Michigan
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148635300
Cites:
Cited by:
Related to: